Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,348 | 490,663 | 403,234 | 303,581 | 146,860 |
| Depreciation Amortization | 11,626 | 40,891 | 30,208 | 19,575 | 9,955 |
| Income taxes - deferred | -1,520 | 42,318 | 35,307 | 26,073 | 13,217 |
| Accounts receivable | 82,407 | -22,272 | 3,502 | -2,332 | -2,217 |
| Accounts payable and accrued liabilities | -235 | -1,578 | 1,890 | 6,310 | 1,950 |
| Other Working Capital | 68,341 | -45,082 | -29,321 | -19,366 | -8,238 |
| Other Operating Activity | -74,197 | 31,037 | -8,178 | -7,258 | 777 |
| Operating Cash Flow | $85,074 | $535,977 | $436,642 | $326,583 | $162,304 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,868 | -17,090 | -10,876 | -4,409 | -2,748 |
| Net Acquisitions | -69,731 | -238,349 | -238,216 | -238,836 | -238,836 |
| Other Investing Activity | 7,869 | -12,173 | 0 | 0 | 0 |
| Investing Cash Flow | $-69,730 | $-267,612 | $-249,092 | $-243,245 | $-241,584 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8,455 | 8,455 | 8,455 | 8,455 |
| Debt Repayment | -1,360 | -13,895 | -12,535 | -11,175 | -9,815 |
| Common Stock Issued | N/A | N/A | 1,993 | N/A | N/A |
| Other Financing Activity | -17,849 | -182,059 | -119,289 | -81,214 | -39,163 |
| Financing Cash Flow | $-19,209 | $-187,499 | $-121,376 | $-83,934 | $-40,523 |
| Beginning Cash Position | 632,138 | 551,272 | 551,272 | 551,272 | 551,272 |
| End Cash Position | 628,273 | 632,138 | 617,446 | 550,676 | 431,469 |
| Net Cash Flow | $-3,865 | $80,866 | $66,174 | $-596 | $-119,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | 85,074 | 535,977 | 436,642 | 326,583 | 162,304 |
| Capital Expenditure | -7,868 | -17,090 | -10,876 | -4,409 | -2,748 |
| Free Cash Flow | 77,206 | 518,887 | 425,766 | 322,174 | 159,556 |